Financials Canopy Growth Corporation

Equities

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. 16:00:00 2024-06-14 EDT 5-day change 1st Jan Change
9.99 CAD -2.82% Intraday chart for Canopy Growth Corporation +3.74% +47.78%

Valuation

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 7,154 15,424 3,737 1,215 1,062 761.2 - -
Enterprise Value (EV) 1 5,643 14,708 3,866 1,739 1,456 1,196 1,278 761.2
P/E ratio -5.38 x -8.61 x -12.3 x -0.34 x -1.33 x -6.93 x -9.12 x -26.6 x
Yield - - - - - - - -
Capitalization / Revenue 17.9 x 28.2 x 7.18 x 3.02 x 3.09 x 2.51 x 2.35 x 2.09 x
EV / Revenue 14.2 x 26.9 x 7.43 x 4.32 x 4.23 x 3.94 x 3.95 x 2.09 x
EV / EBITDA -12.7 x -43.2 x -9.31 x -4.97 x -24.7 x -47 x -2,044 x 34.2 x
EV / FCF -3.82 x -23.3 x -6.64 x -3.07 x -5.1 x -9.4 x -17.4 x 38.6 x
FCF Yield -26.2% -4.28% -15.1% -32.6% -19.6% -10.6% -5.75% 2.59%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 34,965 38,216 39,417 51,264 91,115 76,198 - -
Reference price 2 204.6 403.6 94.80 23.70 11.66 9.990 9.990 9.990
Announcement Date 5/29/20 6/1/21 5/27/22 6/22/23 5/30/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 398.8 546.6 520.3 402.9 343.9 303.4 323.4 364.9
EBITDA 1 -442.8 -340.3 -415.4 -349.7 -58.92 -25.44 -0.6254 22.25
EBIT 1 -1,046 -1,134 -713.3 -2,848 -228.7 -91.09 -62.3 -21.82
Operating Margin -262.23% -207.44% -137.09% -706.94% -66.5% -30.02% -19.26% -5.98%
Earnings before Tax (EBT) 1 -1,509 -1,684 -329.4 -3,314 -471.4 -151.8 -113.4 -75.5
Net income 1 -1,321 -1,745 -302.2 -3,278 -657.3 -132.2 -100.7 -46.26
Net margin -331.35% -319.2% -58.08% -813.63% -191.1% -43.59% -31.15% -12.68%
EPS 2 -38.00 -46.90 -7.700 -70.70 -8.790 -1.442 -1.095 -0.3750
Free Cash Flow 1 -1,478 -630.2 -582.5 -566.8 -285.4 -127.1 -73.46 19.73
FCF margin -370.53% -115.29% -111.95% -140.67% -82.98% -41.9% -22.71% 5.41%
FCF Conversion (EBITDA) - - - - - - - 88.68%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 5/29/20 6/1/21 5/27/22 6/22/23 5/30/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1
Net sales 1 141 111.8 110.1 117.9 101.2 87.54 108.7 69.6 90.06 83.15 73.72 70.22 77.35 79.51 77.14
EBITDA 1 -67.41 -121.8 -74.8 -78.1 -87.5 -95.64 -57.84 -11.86 -8.989 -15.09 -7.718 -4.853 0.7403 3.56 -3.4
EBIT 1 -150 -288.5 -110.2 -175.8 -153.8 -604.7 -87.48 -36.9 -60.32 -106.7 -26.06 -22.48 -17.3 -14.17 -
Operating Margin -106.38% -258.12% -100.12% -149.2% -151.92% -690.82% -80.45% -53.02% -66.97% -128.36% -35.35% -32.01% -22.37% -17.82% -
Earnings before Tax (EBT) 1 -115.7 -587.1 -2,084 -223.7 -267.1 -664 -39.84 -135.3 -231.4 -96.11 -41.95 -38.1 -32.7 -28.68 -
Net income 1 -108.9 -574.6 -2,083 -221.8 -261.6 -640.1 -38.12 -310 -216.8 -82.34 -37.71 -34.08 -29.66 -22.59 -
Net margin -77.27% -514.11% -1,891.79% -188.19% -258.45% -731.23% -35.06% -445.45% -240.72% -99.02% -51.16% -48.53% -38.35% -28.41% -
EPS 2 -2.800 -14.60 -52.30 -4.700 -5.400 -12.80 -0.7000 -4.300 -2.620 -1.030 -0.4750 -0.4225 -0.3625 -0.2850 -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/9/22 5/27/22 8/5/22 11/9/22 2/9/23 6/22/23 8/9/23 11/9/23 2/9/24 5/30/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - - 129 524 394 434 517 -
Net Cash position 1 1,511 716 - - - - - -
Leverage (Debt/EBITDA) - - -0.3113 x -1.499 x -6.683 x -17.07 x -826.7 x -
Free Cash Flow 1 -1,478 -630 -582 -567 -285 -127 -73.5 19.7
ROE (net income / shareholders' equity) -21.7% -27.3% -8.55% -151% -104% -26.9% -10.7% -5.5%
ROA (Net income/ Total Assets) -17.1% -17.2% -4.86% -81.5% -35.1% -8.8% -5.4% -3.4%
Assets 1 7,711 10,167 6,219 4,022 1,870 1,503 1,866 1,361
Book Value Per Share - - - - - - - -
Cash Flow per Share 2 -22.20 -12.50 - -12.00 -3.770 1.440 0.7800 0.1400
Capex 1 705 165 36.7 9.22 3.45 5.2 5.3 10.8
Capex / Sales 176.78% 30.09% 7.05% 2.29% 1% 1.71% 1.64% 2.95%
Announcement Date 5/29/20 6/1/21 5/27/22 6/22/23 5/30/24 - - -
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
13
Last Close Price
9.99 CAD
Average target price
8.89 CAD
Spread / Average Target
-11.01%
Consensus
  1. Stock Market
  2. Equities
  3. WEED Stock
  4. Financials Canopy Growth Corporation